Evidence map›Paper›PMID 29380749›Full record

ArticleBiomedical materials (Bristol, England)2018

Injectable hydrogels of optimized acellular nerve for injection in the injured spinal cord.

R Chase Cornelison, Elisa J Gonzalez-Rothi, Stacy L Porvasnik, Steven M Wellman, James H Park, David D Fuller, Christine E Schmidt

Abstract read
In one paragraph

Article in Biomedical materials (Bristol, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

R Chase CornelisonMcKetta Department of Chemical Engineering, University of Texas at Austin, Austin, TX 78712, United States of America.ORCID 0000-0002-0651-717X
Elisa J Gonzalez-RothiDepartment of Physical Therapy, University of Florida, Gainesville, FL 32611, United States of America.
Stacy L PorvasnikJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611, United States of America.
Steven M WellmanJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611, United States of America.
James H ParkJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611, United States of America.
David D FullerDepartment of Physical Therapy, University of Florida, Gainesville, FL 32611, United States of America.
Christine E SchmidtJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611, United States of America.ORCID 0000-0002-5865-6016
University of Florida · US

Funding

Modulation of Phrenic Motoneuron Plasticity after Cervical Spinal Cord InjuryR01NS080180 · NINDS · UNIVERSITY OF FLORIDA · PI FULLER, DAVID D · 2012 to 2016
$1.7M
Hydrogel Systems for Purification and Differentiation of Mid-Brain NPCsR21NS074162 · NINDS · UNIVERSITY OF TEXAS AT AUSTIN · PI SCHMIDT, CHRISTINE E · 2011 to 2012
$399k
3D Acellular Vascular Beds: Characterization and Re-endothelializationR21EB013358 · NIBIB · UNIVERSITY OF TEXAS AT AUSTIN · PI SCHMIDT, CHRISTINE E · 2011 to 2012
$399k
NIBIB NIH HHS R21 EB013358NINDS NIH HHS R01 NS080180NINDS NIH HHS R21 NS074162
6 · The paper itself

Abstract

objectiveSpinal cord injury (SCI) affects a quarter million individuals in the United States, and there is currently no clinical treatment. Both fresh and acellular peripheral nerve grafts can induce spinal axon regeneration and support functional recovery in experimental injury models. Nonetheless, a scaffold that can be injected into a spinal contusion would be far less invasive to apply. We aimed to develop the first injectable acellular nerve graft for promoting repair after contusion SCI. APPROACH: We report a method to enzymatically solubilize optimized acellular (OA) nerve-a decellularized peripheral nerve graft developed in our laboratory and currently used clinically-to obtain an injectable solution that undergoes thermal gelation under physiological conditions. We quantified multiple physical and compositional properties of this novel material as well as tested its efficacy at acute and chronic time points following cervical contusion SCI. MAIN

resultsThis injectable optimized acellular (iOA) nerve graft retains native chemical cues such as collagens and glycosaminoglycans. By varying hydrogel concentration, the rheological properties and compressive modulus of iOA were similar to that previous reported for rat central nervous tissue. iOA solution was compatible with rat Schwann cells in culture, and hydrogel injection into a rat cervical contusion model significantly reduced the ratio of M1:M2 macrophages after one week, favoring regenerative phenotypes (p < 0.05). Furthermore, while iOA treatment did not affect locomotor or respiratory recovery over an eight week period, the percentage of axonal coverage increased at the distal tissue interface (p < 0.05), suggesting enhanced axonal extension within this region. SIGNIFICANCE: Our data indicate that this novel injectable form of acellular nerve grafts is amenable for use after contusion SCI and may bolster a simultaneous therapy by acutely modulating the inflammatory milieu and supporting axonal growth.

Indexed as

Nerve RegenerationAlginatesAnimalsAxonsCell MovementGlycosaminoglycansHydrogelsMicroscopy, ConfocalNeuronsRatsSchwann CellsSpheroids, CellularSpinal CordSpinal Cord InjuriesTissue EngineeringAlginatesGlycosaminoglycansHydrogels

Identifiers

PMID29380749
PMCPMC5911159
OpenAlexW2793872215

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.